Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines.
about
Efficacy and safety of low-dose doxepin in depressed patients suffering from insomnia: a retrospective, naturalistic case series analysis.Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotypeA generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapyEfficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.Rediscovering trazodone for the treatment of major depressive disorderHistamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.Iloperidone, asenapine and lurasidone: a primer on their current status.Mechanism of action of trazodone: a multifunctional drug.Low-dose doxepin: in the treatment of insomnia.Slow wave activity during sleep: functional and therapeutic implications.Histamine pharmacology and new CNS drug targets.The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.Sites of action of sleep and wake drugs: insights from model organisms.Use of ultra-low-dose (≤6 mg) doxepin for treatment of insomnia in older people.Antibacterial and antifungal metal based triazole Schiff bases.Trazodone for Insomnia: A Systematic Review.Perceived fatigue and energy are independent unipolar states: Supporting evidence.Therapeutic rationale for low dose doxepin in insomnia patients.Low-dose doxepin (3 and 6 mg) for the treatment of insomniaMultifunctional Drugs: A Novel Concept for Psychopharmacology
P2860
Q33721186-AD447366-9A1E-4FE7-87A6-74E56F525DCAQ33796782-F08C536E-BA39-426D-BAC9-06AFAE4441C9Q33884174-2DDA75E0-DF4C-4EB3-B9C1-1679FE22A3A8Q34197699-2F0E98C0-5425-412B-8078-8D7899C0E793Q34314280-25C5E298-A660-47FE-8D9D-300240AFB488Q34348107-4B769D64-6E6F-45D6-BD28-2E17D92E888DQ34641024-96157479-3BAF-4B61-8088-26AEF0FA69EDQ37679880-6022F2E7-8B5C-4057-8484-7D760EC2C67FQ37775613-38489BF9-E0A0-4C51-BDCD-B099B410AB27Q37797832-882AC9E7-444A-4653-9B86-1DF2C218C84DQ37954375-6AAD1978-F8D6-4514-9394-F6DB3B914A8AQ38057380-C8499678-7104-4C22-ADC2-FE097DF81D5FQ38109329-E983337C-98FA-4126-9485-F25343762C8CQ38264419-AD40666A-22AA-4C4F-920B-108BEF93B9CCQ44202195-18E0A11A-588F-4189-9BE0-B1CB905E70FBQ53431638-8C817C0B-19D7-4BCF-9CB2-986938C9D2EAQ53437763-C0E3BD4F-98FE-4E35-9DDA-D9ADC72A1BD9Q55646753-E367A54B-EFCA-4AFA-8802-3EFB7EAE8913Q57487833-241AF71C-1D50-42DD-86F6-1B737DB810ADQ57487836-46CCF8C8-7515-4B4D-B3C2-1405913008BB
P2860
Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective histamine H1 antagon ...... cal notions of antihistamines.
@en
Selective histamine H1 antagon ...... cal notions of antihistamines.
@nl
type
label
Selective histamine H1 antagon ...... cal notions of antihistamines.
@en
Selective histamine H1 antagon ...... cal notions of antihistamines.
@nl
prefLabel
Selective histamine H1 antagon ...... cal notions of antihistamines.
@en
Selective histamine H1 antagon ...... cal notions of antihistamines.
@nl
P2860
P1433
P1476
Selective histamine H1 antagon ...... cal notions of antihistamines.
@en
P2093
Stephen M Stahl
P2860
P304
P356
10.1017/S1092852900017089
P577
2008-12-01T00:00:00Z